Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersOphthalmology Physician in Houston, TX
NPI: 1124013214Primary Employer
Houston Eye Associates
houstoneye.com
HQ Phone
Mobile
Get M.D. Kevin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
1996 - 2025
LA State Medical License
1993 - 2000
OK State Medical License
1996 - 1998
American Board of Ophthalmology
Ophthalmology
Tulane University
Residency • Ophthalmology
1993 - 1996
Baylor College Of Medicine
bcm.edu
Internship • Transitional Year
1992 - 1993
Medical School
Until 1992
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 421 | 445 |
| 2 | 92012Eye and medical examination for diagnosis and treatment, established patient | 190 | 261 |
| 3 | 92133Diagnostic imaging of optic nerve of eye | 164 | 166 |
| 4 | 92004Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 120 | 120 |
| 5 | 92083Measurement of field of vision during daylight conditions | 117 | 119 |
Authors: Joseph Martel, Joseph Martel, Steven Vold, Eric Donnenfeld, Michael Korenfeld
Journal: Clin Ther
Publication Date: 2022-12-08
Authors: Joseph Martel, Satish Modi, Robert Lehmann, Louis Alpern, Glenn Jaffe
Journal: Ophthalmology
Publication Date: 2017-03-06
Lead Sponsor: Bausch & Lomb Incorporated
Intervention / Treatment: DEVICE: Alcon VISCOAT®, DEVICE: Bausch & Lomb DVisc40
Lead Sponsor: Bausch & Lomb Incorporated
Intervention / Treatment: DEVICE: ProVisc OVD, PROCEDURE: Cataract Surgery, DEVICE: CVisc50 OVD
Lead Sponsor: Shire
Intervention / Treatment: OTHER: Placebo, DRUG: PVP-I 0.6%, DRUG: SHP640